Longboard Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	14.33	10.78	66.35	55.32
Short-Term Investments	34.17	56.81	40.38	0
Cash & Cash Equivalents	48.5	67.59	106.73	55.32
Cash Growth	-28.25%	-36.67%	92.94%	-
Other Current Assets	1.72	2.25	1.66	0.05
Total Current Assets	50.22	69.84	108.38	55.36
Property, Plant & Equipment	0.48	0.75	0.54	0
Other Long-Term Assets	0	0.03	0.03	0.88
Total Long-Term Assets	0.48	0.78	0.57	0.88
Total Assets	50.7	70.62	108.95	56.24
Accounts Payable	1	1.31	1.03	1.21
Current Debt	0.48	0.36	0.34	0
Other Current Liabilities	8.3	7.1	4.08	1.92
Total Current Liabilities	9.77	8.76	5.44	3.14
Long-Term Debt	0	0.38	0.19	0
Other Long-Term Liabilities	0	0	0	55.8
Total Long-Term Liabilities	0	0.38	0.19	55.8
Total Liabilities	9.77	9.15	5.63	58.93
Total Debt	0.48	0.74	0.52	0
Debt Growth	-35.81%	41.22%	-	-
Retained Earnings	-140.56	-86.14	-42.2	-14.4
Comprehensive Income	-0.08	-0.69	-0.16	0
Shareholders' Equity	40.92	61.47	103.32	-2.69
Net Cash / Debt	48.02	66.85	106.2	55.32
Net Cash / Debt Growth	-28.16%	-37.05%	91.99%	-
Net Cash Per Share	2.11	3.90	7.37	14.52
Working Capital	40.45	61.07	102.94	52.23
Book Value Per Share	1.80	3.58	7.17	-0.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).